Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

Stock Information for Ardelyx Inc.

Loading

Please wait while we load your information from QuoteMedia.